These final results, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two help the idea of targeting ACKR3 as a unique technique to modulate the opioid system, which could open up new therapeutic avenues for opioid-linked Diseases. Depending on out there https://stephend924jgc5.wikitron.com/user